About the Authors
- Joseph B. Margolick
-
* E-mail: Jmargol1@jhu.edu
Affiliation Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America
- Linda Apuzzo
-
Affiliation Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America
- Joel Singer
-
Affiliation CIHR Canadian HIV Trials Network, Vancouver, British Columbia, Canada
- Hubert Wong
-
Affiliation CIHR Canadian HIV Trials Network, Vancouver, British Columbia, Canada
- Terry Lee
-
Affiliation CIHR Canadian HIV Trials Network, Vancouver, British Columbia, Canada
- Joel E. Gallant
-
Current address: Southwest CARE Center, Santa Fe, New Mexico, United States of America
Affiliation Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland, United States of America
- Phillippe El-Helou
-
Affiliation Department of Medicine, McMaster University, Hamilton, Ontario Canada
- Mona R. Loutfy
-
Affiliation Maple Leaf Medical Clinic, Toronto, Ontario, Canada
- Anita Rachlis
-
Affiliation Sunnybrook Health Sciences, Toronto, Ontario, Canada
- Christopher Fraser
-
Affiliation Cool Aid Community Health Center, Victoria, British Columbia, Canada
- Kenneth Kasper
-
Affiliation Department of Medical Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada
- Cécile Tremblay
-
Affiliation Centre de recherché du Centre Hospitalier de l’ Université de Montréal, Montréal, Quebec, Canada
- Harout Tossonian
-
Affiliation Vancouver Infectious Diseases Centre, Vancouver, British Columbia, Canada
- Brian Conway
-
Affiliation Vancouver Infectious Diseases Centre, Vancouver, British Columbia, Canada
Competing Interests
The authors have read the journal's policy and one author of this manuscript has the following competing interest: Gilead Sciences, GlaxoSmithKline, Bristol-Myers Squibb, and Abbott Laboratories provided antiretroviral medications for this study and additional financial support was provided by Janssen Therapeutics. Gallant: AbbVie (research support), Bristol-Myers Squibb (research support and scientific advisory board), Gilead Sciences (research support and scientific advisory board), Janssen Therapeutics (research support and scientific advisory board), Merck & Co. (research support and scientific advisory board), Sangamo BioSciences (research support), ViiV Healthcare (research support and scientific advisory board). There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: JM JS HW JG BC. Performed the experiments: JM LA JG PE-H ML AR CF KK CT HT BC. Analyzed the data: JS HW TL. Wrote the paper: JM LA JS HW TL JG PE-H ML AR CF KK CT HT BC.